• Alcohol and Other Drugs Group

    Heads: Professor Paul Dietze and Dr Peter Higgs

    Alcohol and other drugs are a major issue in Australia and Burnet has an established reputation in working to alleviate harms associated with their use.

  • Diagnostic Markers in Chronic Immune Disorders Group

    Head: Dr Raffi Gugasyan

    Understanding the role of key signalling molecules that are critical for the normal development and function of T and B lymphocytes.

  • Global Adolescent Health Group

    Co-Heads: Dr Peter Azzopardi and Dr Elissa Kennedy

    Adolescence as a key developmental stage within the life-course, where investments bring a triple dividend of benefits – now, into future adult life, and for the next generation of children.

  • Global Health Diagnostics Development Group

    Head: Associate Professor David Anderson

    There is an unmet need for new and/or improved tests for many diseases that predominantly affect disadvantaged populations.

  • Global Health: policy, practice and community action

    Co-Heads: Lisa Davidson and Chad Hughes.

    Translating research into sustainable health solutions for vulnerable communities through health system strengthening, improved health service delivery and empowering communities.

  • Global Women's and Newborn's Health Group

    Co-Heads: Professor Caroline Homer AO and Dr Joshua Vogel

    Improving health outcomes for at-risk mothers and newborn babies.

  • Healthy Mothers, Healthy Babies (PNG) Group

    Head: Professor James Beeson

    A team of researchers and project staff aiming to define the major causes of poor maternal, newborn and infant care in PNG.

  • HIV Prevention Group

    Head: Professor Mark Stoové

    Conducts innovative research aimed at understanding the transmission and prevention of HIV.

  • HIV, Inflammation and Microbiome Group

    Head: Dr Lindi Masson

    Identifying risk factors for HIV acquisition in young South African women and developing strategies to reduce this risk.

  • Immune Therapies Group

    Head: Professor Mark Hogarth

    Discovering new ways to treat disease by manipulating the immune system.

  • Infection, Inflammation and Innate Immunity Group

    Head: Dr Anna Hearps

    Develop prognostic tools and adjunctive therapies to predict and improve health outcomes for HIV patients.

  • Influenza Group

    Head: Emeritus Professor Greg Tannock

    Researching the causes of variability in the growth of influenza B viruses in eggs and developing methods to increase yields of vaccine antigens.

  • Justice Health

    Head: Professor Mark Stoové

    Undertakes research to build the evidence base for policy and practice to improve outcomes for prisoners and ex-prisoners.

  • Malaria and Infectious Diseases Epidemiology Group

    Head: Professor Freya Fowkes

    Understanding malaria dynamics in populations is key to implementing effective public health control measures.

  • Malaria and Tropical Diseases Group

    Head: Associate Professor Jack Richards

    Improving surveillance, diagnostics, clinical treatment, prevention and disease control for malaria, TB and other tropical diseases.

  • Malaria Immunity and Vaccines Group

    Head: Professor James Beeson

    Research focussed on immunity, vaccines, new treatments and clinical studies of malaria.

  • Viral Hepatitis Elimination Group

    Co-Heads: Professor Margaret Hellard and Dr Joseph Doyle

    Improving the understanding of hepatitis C and its transmission, and the management and care of people already infected with these viruses.

  • Young People's Health

    Head: Dr Megan Lim

    Examines the epidemiology and consequences of risk behaviours among young people.